The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.

PubWeight™: 3.84‹?› | Rank: Top 1%

🔗 View Article (PMC 2747591)

Published in Surg Gynecol Obstet on August 01, 1973

Authors

T E Starzl, A Francavilla, C G Halgrimson, F R Francavilla, K A Porter, T H Brown, C W Putnam

Articles citing this

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61

Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35

Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33

Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28

The hepatotropic influence of cyclosporine. Surgery (1990) 2.27

Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A (1976) 2.23

A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15

The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91

Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci U S A (1975) 1.84

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78

Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74

Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72

The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63

Sex hormone-related functions in regenerating male rat liver. Gastroenterology (1986) 1.51

The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50

Hepatic manifestations of familial patent ductus venosus in adults. Gut (1999) 1.49

Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43

Hemodynamics of the interposition mesocaval shunt. Ann Surg (1975) 1.37

The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33

A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32

Specific endocrine and hormonal receptor changes associated with liver regeneration in adult rats. Proc Natl Acad Sci U S A (1975) 1.31

Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30

Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology (1991) 1.30

Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology (1995) 1.27

Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology (1987) 1.24

Regenerating rat liver: correlations between estrogen receptor localization and deoxyribonucleic acid synthesis. Gastroenterology (1984) 1.19

Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. VII. Hormonal control of DNA synthesis and its possible significance to the problem of liver regeneration. J Cell Biol (1974) 1.19

Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18

Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14

Liver transplantation in patients with portal vein thrombosis and central portacaval shunts. Ann Surg (1991) 1.13

Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg (1976) 1.11

The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet (1978) 1.11

Insight into congenital absence of the portal vein: is it rare? World J Gastroenterol (2008) 1.06

Effects of hormones on the synthesis of alpha 1 (acute-phase) glycoprotein in isolated rat hepatocytes. Biochem J (1977) 1.03

Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am (1988) 1.01

The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology (1989) 1.01

The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology (1987) 0.99

Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis. Gastroenterology (1978) 0.98

Hepatotrophic factors in liver growth and atrophy. Br J Exp Pathol (1985) 0.94

Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases. Mol Cell Biol (1996) 0.94

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Effect of portocaval shunt on residual extreme small liver after extended hepatectomy in porcine. World J Surg (2006) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann Surg (1998) 0.90

Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology (1992) 0.89

Portal circulation and portal hypertension. Gut (1978) 0.89

Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut (2002) 0.88

Effect of gastrin on liver regeneration after partial hepatectomy in rats. Gut (1990) 0.88

Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc (1988) 0.88

Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. IX. Specific inhibition of DNA synthesis initiation by very low density lipoprotein and possible significance to the problem of liver regeneration. J Cell Biol (1976) 0.87

Congenital absence of the portal vein in a middle-aged man. Surg Radiol Anat (2010) 0.87

Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration. Metabolism (1976) 0.82

Segmental difference of the hepatic fibrosis from chronic viral hepatitis due to hepatitis B versus C virus infection: comparison using dual contrast material-enhanced MRI. Korean J Radiol (2011) 0.81

Surgical intervention for patent ductus venosus. Pediatr Surg Int (2010) 0.81

Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy. Hepatology (1983) 0.80

Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology (1993) 0.80

Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro. J Hepatol (1989) 0.79

Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology (1994) 0.79

The hepatic vasculature and its response to hepatic injury: a working hypothesis. Yale J Biol Med (1978) 0.78

Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet (1983) 0.78

The role of hepatotrophic factors in liver regeneration--a brief review including a preliminary report of the in vitro effects of hepatic regenerative stimulator substance (SS). Yale J Biol Med (1979) 0.77

The long reach of liver transplantation. Nat Med (2012) 0.77

Improved results with selective distal splenorenal shunt in a highly selected patient population. A prospective study. Ann Surg (1989) 0.77

Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy. Surg Today (1998) 0.77

Operations for management of esophageal variceal hemorrhage. West J Med (1982) 0.76

Discordance between glucokinase activity and insulin and glucagon receptor changes occurring during liver regeneration in the rat. Horm Metab Res (1984) 0.76

World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75

The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75

Portal diversion. Treatment for glycogen storage disease and hyperlipemia. JAMA (1975) 0.75

Living Donor Liver Transplantation for Unresectable Liver Adenomatosis Associated with Congenital Absence of Portal Vein: A Case Report and Literature Review. Am J Case Rep (2015) 0.75

Radiological findings in a case of multiple focal nodular hyperplasia associated with portal vein atresia and portopulmonary hypertension. Korean J Radiol (2008) 0.75

Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75

Diagnosis Performance of Different MR Imaging Signs of Cirrhosis: the Caudate to Right Lobe Ratio, the Posterior Right Hepatic Notch, and the Expanded Gallbladder Fossa. Curr Health Sci J (2009) 0.75

Surgical resection for colorectal hepatic metastases. Bull N Y Acad Med (1990) 0.75

The ripple effect of liver transplantation. Transplant Proc (1980) 0.75

A Comparison between splenic fossa and subhepatic fossa auxiliary partial heterotopic liver transplantation in a porcine model. Liver Transpl (2016) 0.75

Utility of cone-beam computed tomography in the assessment of the porto-spleno-mesenteric venous system. Cardiovasc Diagn Ther (2016) 0.75

Losartan supports liver regrowth via distinct boost of portal vein pressure in rodents with 90 % portal branch ligation. Dig Dis Sci (2013) 0.75

The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions. Surg Today (2000) 0.75

Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients. Cancer Imaging (2017) 0.75

Articles cited by this

A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1970) 23.79

Uptake of radioactive alanine in vitro into the proteins of rat liver fractions. J Biol Chem (1952) 16.86

The estimation of glycogen with the anthrone reagent. Arch Biochem (1950) 15.85

Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem (1962) 12.79

RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION. J Exp Med (1920) 10.36

IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg (1964) 4.14

Liver regeneration following portacaval transposition in dogs. Ann Surg (1953) 3.23

PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION. Surg Gynecol Obstet (1965) 3.15

Observations on the silicic acid chromatography of the neutral lipides of rat liver, beef liver, and yeast. J Biol Chem (1958) 3.10

Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. J Biol Chem (1968) 2.88

Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. J Biol Chem (1962) 2.77

Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest (1968) 2.46

Glycogen fractions of liver and muscle. J Biol Chem (1951) 2.31

Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain. Biochemistry (1967) 2.09

INSULIN-DEPENDENT SYNTHESIS OF LIVER GLUCOKINASE IN THE RAT. J Biol Chem (1963) 2.03

Experimental aspects of hepatic regeneration. N Engl J Med (1967) 1.88

Sympathetic regulation of metabolism. Pharmacol Rev (1967) 1.73

Effect of insulin on adenosine 3',5'-monophosphate in the rat epididymal fat pad. J Biol Chem (1966) 1.72

Measurement of cyclic 3',5'-denosine monophosphate by the activation of skeletal muscle protein kinase. J Biol Chem (1971) 1.72

THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Surgery (1965) 1.66

Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66

The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54

Control of gluconeogenesis in liver. 3. Effects of L-lactate, pyruvate, fructose, glucagon, epinephrine, and adenosine 3',5'-monophosphate on gluconeogenic intermediates in the perfused rat liver. J Biol Chem (1969) 1.50

The role of cyclic AMP in the control of carbohydrate metabolism. Diabetes (1969) 1.50

Effect of increased hepatic blood flow upon liver regeneration. AMA Arch Surg (1954) 1.50

Evaluation of a humoral factor in liver regeneration utilizing liver transplants. Cancer Res (1971) 1.45

The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34

Regulation of glycogen metabolism in liver by the autonomic nervous system. II. Neural control of glycogenolytic enzymes. Biochim Biophys Acta (1968) 1.32

The role of cyclic AMP in the control of liver metabolism. Adv Enzyme Regul (1968) 1.29

Control of gluconeogenesis in liver. IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver. J Biol Chem (1969) 1.25

HOMOTRANSPLANTATION OF THE CANINE LIVER: SURVIVAL AND HISTOLOGY WITH AND WITHOUT AZATHIOPRINE. Arch Surg (1965) 1.15

Glucagon as the portal factor modifying hepatic regeneration. Surgery (1972) 1.09

Influence of blood supply on regeneration of liver transplants. Surg Forum (1969) 1.08

Demonstration and characterization of a second fraction of glucagon-like immunoreactivity in jejunal extracts. Am J Med Sci (1968) 1.08

Hormonal and nonhormonal control of glycogen metabolism. Trans N Y Acad Sci (1966) 1.08

LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION. Surg Forum (1964) 1.07

Independence of hyperplastic and hypertrhic responses in liver regeneration. Surg Gynecol Obstet (1967) 1.07

The effects of portacaval shunt and portal flow occlusion on canine auxiliary liver homotransplants. Surgery (1967) 1.04

Liver transplantation in the rat. Surg Forum (1966) 1.01

The inter-liver competition and portal blood in regeneration of auxiliary liver transplants. Surg Forum (1971) 0.99

The role of endogenous lipid in gluconeogenesis and ketogenesis of perfused rat liver. Eur J Biochem (1969) 0.98

Increased activities of glycogenolytic enzymes in liver after splanchnic-nerve stimulation. Science (1965) 0.96

Experimental evaluation of liver atrophy and portacaval shunt. Surg Gynecol Obstet (1967) 0.96

Studies of liver lobes autotransplanted outside the abdominal cavity. Surg Gynecol Obstet (1967) 0.95

[Selective portohepatic shunt. Pancreatic origin of the portal hepatotrophic factor]. Ann Chir (1969) 0.94

REGULATION OF CELL LIPID METABOLISM AND ACCUMULATION. 3. THE LIPID CONTENT OF MAMMALIAN CELLS AND THE RESPONSE TO THE LIPOGENIC ACTIVITY OF RABBIT SERUM. Exp Cell Res (1964) 0.90

INVESTIGATIONS CONCERNING THE ROLE OF A HUMORAL FACTOR IN LIVER REGENERATION. Cancer Res (1963) 0.90

EFFECT OF PARTIAL HEPATECTOMY AND ECK FISTULA ON AUTOTRANSPLANTED LIVER TISSUE. EVIDENCE FOR A HUMORAL MECHANISM IN LIVER REGENERATION. Surg Forum (1963) 0.87

Effect of glucagon on phosphorylase activity of the isolated perfused liver. Am J Physiol (1969) 0.85

Influence of the source of portal vein blood on dog auxiliary hepatic allograft function in recipients with hepatic insufficiency. Surg Forum (1971) 0.85

Glycogenolytic effect of adenosine 3',5'-monophosphate in the canine liver. Endocrinology (1966) 0.82

Effect of CCl4 intoxication on the synthesis of beta-lipoprotein fractions in rat liver. Clin Chim Acta (1968) 0.81

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15